AstraZeneca inks China AI research deal for chronic diseases
Sunday, 15 June 2025 () London (AFP) June 13, 2025
British drugmaker AstraZeneca unveiled on Friday an AI-assisted research partnership with Chinese counterpart CSPC Pharmaceuticals worth up to $5.3 billion to tackle chronic diseases. AstraZeneca, which has a pre-existing collaboration with CSPC, announced earlier this year plans to invest $2.5 billion in China. "This strategic research collaboration underscores our commitment to innovat
Sunday, 15 June 2025 ()
London (AFP) June 13, 2025